- CoinStic
- Posts
- LeewayHertz Launches End-to-End Traceability App TraceRX, Available on Google Play Store
LeewayHertz Launches End-to-End Traceability App TraceRX, Available on Google Play Store
Built on the blockchain, TraceRx enables end-to-end traceability for shipment of drugs from the warehouse through the last mile.
Using the security of blockchain and accessibility of cloud computing, TraceRX enables aid organizations and NGOs to keep a tab on the inventory and ease communication across the supply chain.
TraceRx allows all the involved stakeholders such as pharma vendors, procurement manager, country manager, regional manager, field manager and distribution officer to trace the drugs at every step of the supply chain. It maintains data integrity as the drugs’ information is shared with all the stakeholders.
Since every member checks in the medicine’s information before delivering it to another stakeholder, everyone within the network can identify expired and out-of-stock medicines.
The solution solves the following critical problems
Theft: Improved accountability of delivery of the medicines can reduce theft cases.
Inventory Management: Ability to track and check-in drugs continuously across the supply chain has improved inventory management.
Recall: Recalling of a bad drug batch can be done easily with auditable records stored on the blockchain.
TraceRX won first place in the SCORECard 2018 Pitch Competition held at Virginia Bio+Tech Park. The judges chose TraceRX as the winner of the competition because it has good business prospects to scale up. Understanding the TraceRX solution, the lead judge, John Comstock (regional healthcare segment manager for UPS) said,
“There is a practical application for it, and there is a need for it.”
Also, TraceRX was awarded the prize of $10,000 along with a free year-long membership by the Dominion Energy Innovation Center in partnership with Randolph-Macon College (RMC).
AIDEX18 also appreciated TraceRx for their innovative idea and listed it under “5 must-have humanitarian apps.”
LeewayHertz, one of the top blockchain development companies, developed a permissioned blockchain platform using Hyperledger Sawtooth to enable pharma companies to run the businesses effectively and ensure patients’ safety.
From blockchain consulting to designing wireframes and visual designs and blockchain application development, LeewayHertz has assisted TraceRx at every step of the project.
About LeewayHertz
Established in 2007 and headquartered in San Francisco, LeewayHertz was one of the first to deliver a commercial application for the iPhone. The LeewayHertz team of certified user experience and blockchain development experts has designed and produced over 100 enterprise-grade digital platforms for both startups and enterprises which are being used by millions of users across the world.
The team of blockchain developers at LeewayHertz have the potential to work on various blockchain platforms including Ethereum, Hyperledger Fabric, Hyperledger Sawtooth, Hyperledger Indy, Hedera Hashgraph, EOS, Stellar and Neo. They have successfully deployed more than 80 smart contracts and worked on 10+ blockchain projects.
About TraceRx
TraceRx is a distributed ledger platform that delivers end-to-end track and traceability across the entire supply chain using innovative technologies like cloud computing and the blockchain.
This content is sponsored and should be regarded as promotional material. Opinions and statements expressed herein are those of the author and do not reflect the opinions of The Daily Hodl. The Daily Hodl is not a subsidiary of or owned by any ICOs, blockchain startups or companies that advertise on our platform. Investors should do their due diligence before making any high-risk investments in any ICOs, blockchain startups or cryptocurrencies. Please be advised that your investments are at your own risk, and any losses you may incur are your responsibility.
The post LeewayHertz Launches End-to-End Traceability App TraceRX, Available on Google Play Store appeared first on The Daily Hodl.